Virant Diagnostics, INC

Virant Diagnostics, INC was paid $4.32M by Medicaid between Oct 2020 and Dec 2024, across 10 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#17 of 93

Median peer was paid$430K

This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	328	$3K
2021	29,990	$375K
2022	86,431	$2.59M
2023	14,483	$964K
2024incomplete	9,462	$390K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	71%	68,282	31,802	$3.05M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	19%	8,573	6,996	$810K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	5.2%	53,920	23,742	$226K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.6%	2,709	2,580	$111K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.3%	4,177	3,801	$56K
87631		<1%	2,408	2,088	$37K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	149	149	$21K
86328		<1%	398	254	$9K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	13	13	$124.00
99000		<1%	65	44	$16.04

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLI, HUAMIN (DIRECTOR)